Bulletin Updates

Bayer’s Outlook Rises — Can It Beat the Courtroom? – 6 Aug 2025

Aug 06, 2025

Guidance is higher, yet €1.7bn in litigation provisions loom

Currency headwinds gnaw at earnings

Debt is falling — but for how long?

What’s Bayer’s real escape plan?

The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »